Adhesion molecule expression and function of primary endothelial cells in benign and malignant tissues correlates with proliferation

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Sievert, Wolfgang ^a,b   Tapio, Soile ^b   Breuninger, Stephanie ^a,b   Gaipl, Udo ^c   Andratschke, Nicolaus ^a,b   Trott, Klaus Rüdiger ^d   Multhoff, Gabriele ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; CELL ADHESION MOLECULE; ENDOGLIN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; VASCULAR ENDOTHELIAL CADHERIN; BIOLOGICAL MARKER; MEMBRANE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BENIGN TUMOR; BLASTEMA; CELL ADHESION; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HEART; LUNG; MALE; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR GROWTH; AGE; ANIMAL; ANTIBODY SPECIFICITY; GENETICS; IMMUNOPHENOTYPING; METABOLISM; NEOPLASM; QUALITY CONTROL;

AGE FACTORS; ANIMALS; ANTIGENS, SURFACE; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; CELL PROLIFERATION; ENDOTHELIAL CELLS; FEMALE; IMMUNOPHENOTYPING; MALE; MICE; NEOPLASMS; ORGAN SPECIFICITY; QUALITY CONTROL;

EID: 84897981026     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091808     Document Type: Article

References (45)

1. Helmlinger G, Yuan F, Dellian M, Jain RK (1997) Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med 3: 177-182. (Pubitemid 27064702)
2. Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, et al. (2004) Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 56: 549-580. (Pubitemid 39658463)
3. Hobson B, Denekamp J (1984) Endothelial proliferation in tumours and normal tissues: continuous labelling studies. Br J Cancer 49: 405-413. (Pubitemid 14125248)
4. Reynolds LP, Redmer DA (2001) Angiogenesis in the placenta. Biol Reprod 64: 1033-1040. (Pubitemid 32239172)
5. n J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31.
6. Denekamp J, Hill S (1991) Angiogenic attack as a therapeutic strategy for cancer. Radiother Oncol 20 Suppl 1: 103-112.
7. Hendry JH, Akahoshi M, Wang LS, Lipshultz SE, Stewart FA, et al. (2008) Radiation-induced cardiovascular injury. Radiat Environ Biophys 47: 189-193.
8. Schultz-Hector S, Trott KR (2007) Radiation-induced cardiovascular diseases - is the epidemiologic evidence compatible with the radiobiologic data? Int J Radiat Oncol Biol Phys 67: 10-18. (Pubitemid 44959506)
9. Haveman J, Rodermond H, van Bree C, Wondergem J, Franken NA (2007) Residual late radiation damage in mouse stromal tissue assessed by the tumor bed effect. J Radiat Res 48: 107-112. (Pubitemid 46535894)
10. Garlanda C, Parravicini C, Sironi M, De Rossi M, Wainstok de Calmanovici R, et al. (1994) Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middle-sized T antigen - implications for the pathogenesis of opportunistic vascular tumors. Proc Natl Acad Sci U S A 91: 7291-7295.
11. Pusztaszeri MP, Seelentag W, Bosman FT (2006) Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem 54: 385-395.
12. Stockinger H, Gadd SJ, Eher R, Majdic O, Schreiber W, et al. (1990) Molecular characterization and functional analysis of the leukocyte surface protein CD31. J Immunol 145: 3889-3897.
13. Scholz D, Schaper J (1997) Platelet/endothelial cell adhesion molecule-1 (PECAM-1) is localized over the entire plasma membrane of endothelial cells. Cell Tissue Res 290: 623-631. (Pubitemid 27522263)
14. Postiglione L, Di Domenico G, Caraglia M, Marra M, Giuberti G, et al. (2005) Differential expression and cytoplasm/membrane distribution of endoglin (CD105) in human tumour cell lines: Implications in the modulation of cell proliferation. Int J Oncol 26: 1193-1201.
15. Vestweber D (2008) VE-cadherin - the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 28: 223-232.
16. Navarro P, Ruco L, Dejana E (1998) Differential localization of VE- and N-cadherins in human endothelial cells VE-cadherin competes with N-cadherin for junctional localization. J Cell Biol 140: 1475-1484. (Pubitemid 28152995)
17. Lin G, Finger E, Gutierrez-Ramos JC (1995) Expression of CD34 in endothelial cells, hematopoietic progenitors and nervous cells in fetal and adult mouse tissues. Eur J Immunol 25: 1508-1516.
18. Podgrabinska S, Braun P, Velasco P, Kloos B, Pepper MS, et al. (2002) Molecular characterization of lymphatic endothelial cells. Proc Natl Acad Sci U S A 99: 16069-16074. (Pubitemid 35462750)
19. Fiedler U, Christian S, Koidl S, Kerjaschki D, Emmett MS, et al. (2006) The sialomucin CD34 is a marker of lymphatic endothelial cells in human tumors. Am J Pathol 168: 1045-1053. (Pubitemid 43327754)
20. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA (1986) Induction by IL-1 and interferon-gamma - tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 137: 245-254. (Pubitemid 16100296)
21. Park S, DiMaio TA, Scheef EA, Sorenson CM, Sheibani N (2010) PECAM-1 regulates proangiogenic properties of endothelial cells through modulation of cell-cell and cell-matrix interactions. Am J Physiol Cell Physiol 299: C1468-1484.
22. Zhou Z, Christofidou-Solomidou M, Garlanda C, DeLisser HM (1999) Antibody against murine PECAM-1 inhibits tumor angiogenesis in mice. Angiogenesis 3: 181-188. (Pubitemid 129644645)
23. Solowiej A, Biswas P, Graesser D, Madri JA (2003) Lack of platelet endothelial cell adhesion molecule-1 attenuates foreign body inflammation because of decreased angiogenesis. Am J Pathol 162: 953-962. (Pubitemid 36237502)
24. Brooks PC, Clark RA, Cheresh DA (1994) Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264: 569-571.
25. Steri V, Ellison TS, Gontarczyk AM, Weilbaecher K, Schneider JG, et al. (2014) Acute depletion of endothelial beta 3-integrin transiently inhibits tumor growth and angiogenesis in mice. Circ Res 114: 79-91.
26. Arthur HM, Ure J, Smith AJ, Renforth G, Wilson DI, et al. (2000) Endoglin, an ancillary TGF beta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol 217: 42-53. (Pubitemid 30046798)
27. Burrows FJ, Derbyshire EJ, Tazzari PL, Amlot P, Gazdar AF, et al. (1995) Upregulation of endoglin on vascular endothelial cells in human solid tumors-implications for diagnosis and therapy. Clin Cancer Res 1: 1623-1634. (Pubitemid 26030991)
28. Dallas NA, Samuel S, Xia L, Fan F, Gray MJ, et al. (2008) Endoglin (CD105) - a marker of tumor vasculature and potential target for therapy. Clin Cancer Res 14: 1931-1937. (Pubitemid 351551101)
29. Fonsatti E, Maio M (2004) Highlights on endoglin (CD105) - from basic findings towards clinical applications in human cancer. J Transl Med 2: 18.
30. Carmeliet P, Lampugnani MG, Moons L, Breviario F, Compernolle V, et al. (1999) Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98: 147-157. (Pubitemid 29344903)
31. Vittet D, Buchou T, Schweitzer A, Dejana E, Huber P (1997) Targeted null-mutation in the vascular endothelial-cadherin gene impairs the organization of vascular-like structures in embryoid bodies. Proc Natl Acad Sci U S A 94: 6273-6278. (Pubitemid 27270674)
32. Crosby CV, Fleming PA, Argraves WS, Corada M, Zanetta L, et al. (2005) VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly. Blood 105: 2771-2776. (Pubitemid 40446268)
33. Liao F, Li Y, O'Connor W, Zanetta L, Bassi R, et al. (2000) Monoclonal antibody to vascular endothelial-cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasis. Cancer Res 60: 6805-6810. (Pubitemid 32059142)
34. Liao F, Doody JF, Overholser J, Finnerty B, Bassi R, et al. (2002) Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability. Cancer Res 62: 2567-2575. (Pubitemid 34462736)
35. Corada M, Zanetta L, Orsenigo F, Breviario F, Lampugnani MG, et al. (2002) A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability. Blood 100: 905-911. (Pubitemid 34832616)
36. Li C, Issa R, Kumar P, Hampson IN, Lopez-Novoa JM, et al. (2003) CD105 prevents apoptosis in hypoxic endothelial cells. J Cell Sci 116: 2677-2685. (Pubitemid 36857221)
37. Wood HB, May G, Healy L, Enver T, Morriss-Kay GM (1997) CD34 expression patterns during early mouse development are related to modes of blood vessel formation and reveal additional sites of hematopoiesis. Blood 90: 2300-2311. (Pubitemid 27392714)
38. Maltby S, Freeman S, Gold MJ, Baker JH, Minchinton AI, et al. (2011) Opposing roles for CD34 in B16 melanoma tumor growth alter early stage vasculature and late stage immune cell infiltration. PLoS One 6: e18160.
39. Hubbard AK, Rothlein R (2000) Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades. Free Radic Biol Med 28: 1379-1386. (Pubitemid 30623498)
40. Miele ME, Bennett CF, Miller BE, Welch DR (1994) Enhanced metastatic ability of TNF-alpha-treated malignant melanoma cells is reduced by intercellular adhesion molecule-1 (ICAM-1, CD54) antisense oligonucleotides. Exp Cell Res 214: 231-241. (Pubitemid 24302397)
41. Rosette C, Roth RB, Oeth P, Braun A, Kammerer S, et al. (2005) Role of ICAM1 in invasion of human breast cancer cells. Carcinogenesis 26: 943-950. (Pubitemid 41214323)
42. Xu H, Bickford JK, Luther E, Carpenito C, Takei F, et al. (1996) Characterization of murine intercellular adhesion molecule-2. J Immunol 156: 4909-4914. (Pubitemid 26174479)
43. Huang MT, Mason JC, Birdsey GM, Amsellem V, Gerwin N, et al. (2005) Endothelial intercellular adhesion molecule (ICAM)-2 regulates angiogenesis. Blood 106: 1636-1643. (Pubitemid 41208576)
44. Fidler IJ (1975) Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res 35: 218-224.
45. Ikubo A, Aoki Y, Nagai E, Suzuki T (1999) Highly metastatic variant of a mouse colon carcinoma cell line, LM17 and its response to GM-CSF gene therapy. Clin Exp Metastasis 17: 849-855.